Abiomed (ABMD) Tops Q3 EPS by 3c; Narrows Margin Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Abiomed (ABMD) Tops Q3 EPS by 3c; Narrows Margin Guidance

Abiomed Announces Q3 FY 2019 Record Revenue of $201 Million, up 30% over Prior Year

January 31, 2019 7:00 AM EST

Achieved Record Operating Margin of 31%

DANVERS, Mass.--(BUSINESS WIRE)-- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported third quarter fiscal 2019 revenue of $200.6 million, an increase of 30% compared to revenue of $154.0 million for the same period of fiscal 2018. Third quarter fiscal 2019 GAAP net income was $44.9 million or $0.97 per diluted share, up 235% compared to GAAP net... More